Prevalence of hepatitis C virus genotypes in the Northern of Iran (Mazandaran) from 2009 to 2011

HealthMED

Volumn 6, Issue 9, 2012, Pages 3046-3050

  Haghshenas, Mohammadreza ^a   Babamahmoodi, Farhang ^b   Rafiei, Alireza ^a   Vahedi, Vahid ^b   Alizadeh Navaei, Reza ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genotype of HCV; Hepatitis C virus; RT PCR

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS CHARACTERIZATION;

EID: 84869741114     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Keshvari M, Alavian SM, Behnava B, Miri SM, Elizee PK, Tabatabaei SV, et al. Distribution of hepatitis C Virus genotypes in Iranian patients with congenital bleeding disorders. Iran Red Cres Med J 2010; 12(6): 608-614.
2. Braga EL, Lyra AC, Ney-Oliveira F, Nascimento L, Silva A, Brites C, et al. Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV. Braz J Infect Dis 2006; 10(1): 17-21.
3. Sarbah SA, Younossi ZM. Hepatitis C: an update on the silent epidemic. Iran Red Crescent Med J 2010; 12(6): 608-614.
4. Hamissi J, Mosalaei S, Yousef J, Ghoudosi A, Hamissi. Occurrence of hepatitis B and C infection among hemodialyzed patients with chronic renal failure in Qazvin, Iran: a preliminary study. Healthmed 2011; 5(2): 301-6.
5. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, Zand V, Azami AA, Hosseini MM, Faridi AR, Davari K, Hajibeigi B. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006 Oct; 9(4): 319-323.
6. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health. 2001; 37(6): 564-566.
7. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002; 9(5): 390-392.
8. Kashef S, Karimi M, Amirghofran Z, Ayatollahi M, Pasalar M, Ghaedian MM, Kashef MA. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int J Lab Hematol. 2008; 30(1): 11-16.
9. Arababadi MK, Hassanshahi G, Yousefi H, Zarandi ER, Moradi M, Mahmoodi M. No detected hepatitis B virus-DNA in thalassemic patients infected by hepatitis C virus in Kerman province of Iran. Pak J Biol Sci. 2008; 11(13): 1738-1741.
10. Lauer GM, Walker BD. Hepatitis C virus infection. Review Article. N Engl J Med 2001; 345(1): 41-52.
11. Bukh J, Miller RH, Purcell H, Genetic heterogeneity of hepatitis C virus; quasispecies and genotypes. Semin Liver Dis 1995; 15(1): 41-63.
12. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42(4): 962-973.
13. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125(8): 634-639.
14. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122(3):161-168.
15. Maieron A, Metz-Gercek S, Hackl F, Luger C, Ziachehabi A, Strauss R, et al. Chronic hepatitis C in Austria, 1992-2006: genotype distribution and demographic factors. Euro Surveill 2010; 15(8): 19492.
16. Dehesa-Violante M, Bosques-Padilla F, Kershenobich-Stalnikowitz D. Prevalence of hepatitis C virus genotypes in Mexican patients. Rev Gastroenterol Mex 2007; 72(4): 344-348.
17. Cenci M, De Soccio G, Recchia O. Prevalence of hepatitis C virus (HCV) genotypes in central Italy. Anticancer Res 2003; 23(6D): 5129-5132.
18. Singh S, Malhotra V, Sarin SK. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res 2004; 119(4): 145-148.
19. Sy T, Jamal MM. Epidemiology of Hepatitis C Virus (HCV) Infection. Int J Med Sci 2006; 3(2): 41-46
20. Farshadpour F, Makvandi M, Samarbafzdeh AR, Jalalifar MA. Determination of Hepatitis C Virus genotypes among blood donors in Avaz, Iran. Indian J Med Microbiol 2010; 28(1): 54-56.
21. SamimRad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia 2007; 13(2): 156-63
22. Omrani M, Khadem Ansari MH. Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran. Hepat Mon 2009; 9(2): 133-6.
23. Amini S, Farahani Majd Abadi M, Alavian SM, Joulaie M, Ahmadipour MH. Distribution of Hepatitis C Virus Genotypes in Iran: A Population-Based Study. Hepat Mon. 2009; 9(2): 95-102.
24. Makhloogh A, Aezinia N, Haghshenas MR, Tirgarfakheri H, Maleki I, Taghvaei T, et al. Comparison of Hepatitis C Virus Genotypes in Hemodialysis and Nonuremic Patients. Armaghane-danesh 2010; 15(3): 283-92.
25. Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, Lankarani KB. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. 2009; 49(10): 2195-9.
26. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339: 1485-1492.
27. Goessens C, Jadoul M, Walon C, Burtonboy G, Cornu C. Hepatitis C virus genotypes in hemodialyzed patients: a multicentric study. Clin Nephrol 1997; 47(6): 367-71
28. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi J Kidney Dis Transpl 2008; 19(3): 461-5
29. Hejazi MS, Ghotaslou R, Hagh MF, Sadigh YM. Genotyping of Hepatitis C Virus In Northwest of Iran. Biotechnology 2007; 6(3): 302-308
30. Cenci M, De-Soccio G and Recchia O. Prevalence of hepatitis C virus genotypes in central Italy. Anticancer Res 2003; 23(6D): 5129-32.
31. Sy T, Jamal M. Epidemiology of Hepatitis C virus (HCV) infection. Review article. Int J Med Sci 2006; 3(2): 41-6
32. Akkaya O, Kiyici M, Yilmaz T, Ulukaya E and Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol 2007; 13(41): 5481-5.
33. Abraham R, Ramakrishna B, Balekuduru A. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease. Indian J Gastroenterol 2009: 28(2): 53-8.
34. Mihan S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopatholigical manifestations of chronic hepatitis C virous infection with respect to virous genotype. Hepatology 1997; 25: 735-9.
35. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in. Iran: Epidemiology of an emerging infection. Arch. Iran Med 2005; 8(2) 84-90.
36. de Torres M and Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2003; 2(1): 5-11
37. Poynard T, Ratziu V, Charlotte, F Goodman Z, McHutchison J, Albercht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34(5): 730-9